Subsequent Events (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Nov. 19, 2020 |
Oct. 28, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
Issuance of common stock | $ 2,254,500 | $ 4,204,500 | |||
Common Stock [Member] | |||||
Issuance of common stock | $ 4,509 | $ 500 | $ 8,409 | ||
Subsequent Event [Member] | Common Stock [Member] | |||||
Issuance of common stock | $ 250,000 | ||||
Subsequent Event [Member] | SWC Medical LLC [Member] | |||||
Proceeds from preferred stock | $ 50,000 | ||||
Number of units sold | 5,000 | ||||
Number of warrants to purchase common stock | 50 | ||||
Exercise price of warrants | $ 0.25 | ||||
Subsequent Event [Member] | Chief Executive Officer [Member] | |||||
Advance received from officer | $ 50,000 | ||||
Debt interest rate, percentage | 6.00% |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|